These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trial. Naccaratto R; Cremer M; Dammann HG; Keohane PP; Mulder H; Sarles H; Simon B Scand J Gastroenterol Suppl; 1987; 136():71-8. PubMed ID: 2892258 [TBL] [Abstract][Full Text] [Related]
5. [Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism]. Simon B; Bergdolt H; Dammann H; Müller P Z Gastroenterol; 1991 May; 29(5):217-21. PubMed ID: 1950028 [TBL] [Abstract][Full Text] [Related]
6. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe. Simon B; Cremer M; Dammann HG; Hentschel E; Keohane PP; Mulder H; Müller P; Sarles H Scand J Gastroenterol Suppl; 1987; 136():61-70. PubMed ID: 2892257 [TBL] [Abstract][Full Text] [Related]
7. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee. Yeomans ND Am J Med; 1998 Mar; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322 [TBL] [Abstract][Full Text] [Related]
8. Omeprazole 20 or 40 mg daily for healing gastroduodenal ulcers in patients receiving non-steroidal anti-inflammatory drugs. Massimo Claar G; Monaco S; Del Veccho Blanco C; Capurso L; Fusillo M; Annibale B Aliment Pharmacol Ther; 1998 May; 12(5):463-8. PubMed ID: 9663727 [TBL] [Abstract][Full Text] [Related]
9. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial. Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089 [TBL] [Abstract][Full Text] [Related]
10. Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention. Rodríguez de la Serna A; Díaz-Rubio M J Rheumatol; 1994 May; 21(5):927-33. PubMed ID: 8064736 [TBL] [Abstract][Full Text] [Related]
11. Iron deficiency anaemia in patients with rheumatic disease receiving non-steroidal anti-inflammatory drugs: the role of upper gastrointestinal lesions. Upadhyay R; Torley HI; McKinlay AW; Sturrock RD; Russell RI Ann Rheum Dis; 1990 Jun; 49(6):359-62. PubMed ID: 2383058 [TBL] [Abstract][Full Text] [Related]
12. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Ekström P; Carling L; Wetterhus S; Wingren PE; Anker-Hansen O; Lundegårdh G; Thorhallsson E; Unge P Scand J Gastroenterol; 1996 Aug; 31(8):753-8. PubMed ID: 8858742 [TBL] [Abstract][Full Text] [Related]
13. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802 [TBL] [Abstract][Full Text] [Related]
14. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study. Bianchi Porro G; Lazzaroni M; Petrillo M; Manzionna G; Montrone F; Caruso I Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264 [TBL] [Abstract][Full Text] [Related]
15. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs. ten Wolde S; Dijkmans BA; Janssen M; Hermans J; Lamers CB Aliment Pharmacol Ther; 1996 Jun; 10(3):347-51. PubMed ID: 8791962 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy of antihelicobacter therapy in NSAID-induced gastropathies]. Karateev AE; Murav'ev IuV; Radenska-Lopovok SG; Nasonova VA Klin Med (Mosk); 2003; 81(8):37-41. PubMed ID: 14520944 [TBL] [Abstract][Full Text] [Related]
17. Nizatidine versus placebo in active benign gastric ulcer disease: an eight-week, multicenter, randomized, double-blind comparison. The Nizatidine Benign Gastric Ulcer Disease Study Group. Cloud ML; Enas N; Offen WW Clin Pharmacol Ther; 1992 Sep; 52(3):307-13. PubMed ID: 1526089 [TBL] [Abstract][Full Text] [Related]
18. The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis. Van Groenendael JH; Markusse HM; Dijkmans BA; Breedveld FC Clin Rheumatol; 1996 Sep; 15(5):450-6. PubMed ID: 8894357 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of non-steroidal anti-inflammatory drug-induced damage to gastric mucosa using ranitidine. Comparison of the effectiveness of 2 dosages]. Müller P; Dammann HG; Marinis E; Weise D; Simon B Fortschr Med; 1989 Oct; 107(31):667-70. PubMed ID: 2687142 [TBL] [Abstract][Full Text] [Related]
20. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]